Fulvestrant Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
OLMA | D | Olema Pharmaceuticals, Inc. | 3.02 | |
GTHX | A | G1 Therapeutics, Inc. | 0.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
QQQS | D | Invesco NASDAQ Future Gen 200 ETF | 1.04 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.87 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.5 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 0.42 | |
XBI | D | SPDR S&P Biotech ETF | 0.17 |
Compare ETFs
- Fulvestrant
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.Fulvestrant was approved for medical use in the United States in 2002.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles